HIGHLIGHTS
- who: Kathleen Ruchalski from the Department of Radiological Sciences, UCLA, Los Angeles, CA, USA have published the research work: Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression, in the Journal: (JOURNAL)
- what: The aim of this study is to evaluate the anatomic site(s) of initial disease progression when visceral metastases are present prior to treatment in mCRPC patients.
- how: Patients who met the inclusion criteria for this study were identified from an anonymized imaging clinical trial database of patients with mCRPC in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.